Summary : -The partnership between Oxford University and SEEQC promises to accelerate the use of quantum computing within pharmaceutical research in order…
ChemRobotics Pvt. Ltd. © 2023, All Rights Reserved.
Designed and Developed by Ample eBusiness
Tag:
Phase
-
-
AgrochemicalsGlobal Market
New Johnson & Johnson CEO Duato points out 5 Pipeline Meds that can Generate $5B+
by adminby adminSynopsis: –By 2025, the company aims to generate $60 billion in pharma sales, leaning mostly on existing medicines for growth until then,…
-
Synopsis: The test is a technological first in determining the metastatic status of a cancer without using prior insight of the primary…
-
AgrochemicalsGlobal Market
Nordic Nanovector Provides update on PARADIGME, its Phase 2b Pivotal Trial with Betalutin® in R/R Follicular Lymphoma
by adminby adminSummary : –Nordic Nanovector ASA (OSE: NANOV) provides an update on the timeline for PARADIGME, its ongoing pivotal Phase 2b trial of Betalutin® (177Lu…
-
AgrochemicalsGlobal Market
AstraZeneca completes transfer of global rights to Eklira & Duaklir to Covis Pharma
by adminby adminSummary : AstraZeneca has completed the transfer of its global rights to Eklira (aclidinium bromide), known as Tudorza in the US, and…
-
RegulatoryU.S FDA
US FDA approves expanded MRI compatibility for Abbott’s Proclaim XR Spinal Cord Stimulation System
by adminby adminSummary : -Abbott, a global healthcare leader, announced that the US Food and Drug Administration (FDA) has approved new expanded magnetic resonance…
-
AgrochemicalsGlobal Market
Clover and Ascentage Pharma Announce Clinical Collaboration to Evaluate Recombinant Human TRAIL-Trimer Fusion Protein, SCB-313, in Combination with IAP Antagonist, APG-1387 for the Treatment of Peritoneal Carcinomatosis
by adminby adminSummary : Clover Biopharmaceuticals, Ltd. (Clover; Stock Code: 2197.HK), a global clinical-stage biotechnology company developing novel vaccines and biologic therapeutic candidates and…
-
Covid DrugsGlobal Market
Valneva Confirms Clinical Trial and Regulatory Submission Timelines for its Inactivated COVID-19 Vaccine Candidate VLA2001
by adminby adminSummary: -Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today confirms the previously communicated timelines of its clinical trials…
-
Agrochemicals
Aptinyx Set in Motion Phase 2b Study of NYX-783 in Patients with Post-Traumatic Stress Disorder
by adminby adminSynopsis: Aptinyx Inc., a clinical-stage biopharmaceutical company, announced the initiation of a phase 2b study evaluating 50 mg QD of NYX-783 in…
-
Synopsis: AbbVie’s blockbuster hopeful Rinvoq notched a win in a tricky-to-treat group of Crohn’s disease patients. The trial studied the AbbVie drug…